NF1 MUTATION
Clinical trials for NF1 MUTATION explained in plain language.
Never miss a new study
Get alerted when new NF1 MUTATION trials appear
Sign up with your email to follow new studies for NF1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to shrink painful NF1 tumors
Disease control Recruiting nowThis early-stage study is testing a new oral medication called PAS-004 in adults with Neurofibromatosis Type 1 (NF1) who have painful, inoperable, or recurring plexiform neurofibroma tumors. The main goals are to find a safe dose, understand the side effects, and see if the drug …
Matched conditions: NF1 MUTATION
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New oral cancer drug enters first human safety testing
Disease control Recruiting nowThis is the first study in humans testing PAS-004, an oral medication designed to target specific genetic mutations found in advanced solid tumors. The main goal is to find a safe dose and understand side effects in 48 adults whose cancers have progressed despite standard treatme…
Matched conditions: NF1 MUTATION
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC